Skip to main content
Signal8

Fairmount Funds Management LLC

Fairmount Funds Management LLC is an Investment Adviser institutional filer with the SEC under CIK 1802528, reporting 12 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Fairmount Funds Management LLC's most recent 13F filing, ranked by reported market value.

  1. ORUKA THERAPEUTICS INC (ORKA)
  2. DIANTHUS THERAPEUTICS INC (DNTH)
  3. DAMORA THERAPEUTICS INC (GLTO)
  4. COGENT BIOSCIENCES INC (COGT)
  5. JADE BIOSCIENCES INC (JBIO)
  6. ENLIVEN THERAPEUTICS INC (ELVN)
  7. VIRIDIAN THERAPEUTICS INC (VRDN)
  8. ZENAS BIOPHARMA INC (ZBIO)
  9. CRESCENT BIOPHARMA INC. (CBIO)
  10. APOGEE THERAPEUTICS INC (APGE)
/